COVID-19 April update

As the COVID-19 pandemic continues to evolve, we are also continuing to evolve the way we work – from the running of our trials to how we fundraise to ensure our research continues to help those affected by GI cancer now and in the future.

Clinical trials:

COVID-19 has had a tremendous impact on our clinicians and research professionals on the frontline. While two of our trials have temporarily suspended patient enrolment, we are happy to report the majority of our trials are continuing to enrol patients. Great efforts are being made to ensure patients are kept informed and continue with study treatments. We continue to work closely with Study Chairs, coordinating centres, and drug suppliers to minimise any potential impacts, and to ensure patient and research personnel safety remains the top priority.

Community fundraising:

Due to COVID-19, we postponed our Gutsy challenges until 2021, and many community fundraising events cannot happen during social distancing. But the impact of GI cancer on patients doesn’t stop during the COVID-19 pandemic and neither does the need to fundraise to continue our research, so we are excited to launch a virtual fundraising campaign next week. Please keep an eye out and get involved however you can, be it holding a fundraiser, making a donation, or promoting it to your friends and family.

Member Events:

  • The Annual General Meeting scheduled for 15 May will go ahead with virtual participation encouraged via Zoom video conference.
  • The 22nd Annual Scientific Meeting will now take place as a one-day virtual event on Friday 28 August. We look forward to sharing more updates in the coming weeks.

Resources:

In these uncertain times, we understand that many people in the GI cancer community may be feeling heightened concern about COVID-19. If you are worried about what COVID-19 means for you or your loved ones, please speak with your clinician or hospital, or access the following helpful resources:

  • Cancer Australia has a dedicated web section providing relevant, evidence-based COVID-19 information for people with cancer and health professionals.
  • Coronavirus Health Information Line – 1800 020 080. Call this number if you are seeking information on COVID-19.
  • Our resources section includes a support group directory, recommended reading and other helpful links.
  • A helpful patient video regarding treatment and support during this time.

 

Stay well,

Russell Conley

Chief Executive Officer

 

Share